Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 2/20 | 0.48 |
| ▸ | KDM1A | O60341 | 4/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.43 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.39 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.39 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.39 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29593884 | 1.00 | ANPEP (0.48) | ANPEPKDM1AHTR2ASIGMAR1GRIN2D | |
| SCHEMBL29775131 | 1.00 | ANPEP (0.48) | ANPEPKDM1AHTR2ASIGMAR1GRIN2D | |
| SCHEMBL1002064 | 1.00 | ANPEP (0.48) | ANPEPKDM1AHTR2ASIGMAR1GRIN2D | |
| SCHEMBL83474 | 1.00 | ANPEP (0.48) | ANPEPKDM1AHTR2ASIGMAR1GRIN2D | |
| SCHEMBL163841 | 1.00 | ANPEP (0.48) | ANPEPKDM1AHTR2ASIGMAR1GRIN2D | |
| SCHEMBL1161605 | 1.00 | ANPEP (0.48) | ANPEPKDM1AHTR2ASIGMAR1GRIN2D | |
| SCHEMBL674106 | 1.00 | ANPEP (0.48) | ANPEPKDM1AHTR2ASIGMAR1GRIN2D | |
| SCHEMBL3216510 | 1.00 | ANPEP (0.48) | ANPEPKDM1AHTR2ASIGMAR1GRIN2D | |
| SCHEMBL5635861 | 1.00 | ANPEP (0.48) | ANPEPKDM1AHTR2ASIGMAR1GRIN2D | |
| SCHEMBL163842 | 1.00 | ANPEP (0.48) | ANPEPKDM1AHTR2ASIGMAR1GRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115380027-B | Novel antimalarial agents | 肯塔基大学研究基金会 | 2024-10-18 | — | — | CN | claimed |
| CN-118307532-A | N2 substituted triazole-oxazoline chiral compound and preparation method and application thereof | 吉林大学 | 2024-07-09 | — | — | CN | claimed |
| CN-115380027-A | Novel antimalarial agents | 肯塔基大学研究基金会 | 2022-11-22 | — | — | CN | claimed |
| WO-2026088071-A1 | SUBSTITUTED FUSED HETEROARYL LACTAM COMPOUNDS | PFIZER INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| CN-115380027-B | Novel antimalarial agents | 肯塔基大学研究基金会 | 2024-10-18 | — | — | CN | disclosed |
| CN-118647612-A | Imidazolinone derivatives as inhibitors of protein kinases, in particular DYRK1A, CLK1 and/or CLK4 | 珀哈制药公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-118307532-A | N2 substituted triazole-oxazoline chiral compound and preparation method and application thereof | 吉林大学 | 2024-07-09 | — | — | CN | disclosed |
| CN-117510547-A | Spiro chiral platinum (II) and palladium (II) complex circularly polarized luminescent material and application thereof | 浙江工业大学 | 2024-02-06 | — | — | CN | disclosed |
| CN-116848107-A | Compounds and their use as PDE4 activators | 米罗尼德有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116096712-A | Novel compounds | NRG治疗有限公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-115836058-A | Benzisoxazole derivatives | 住友制药株式会社 | 2023-03-21 | — | — | CN | disclosed |
| EP-4132918-A1 | NEW ANTI-MALARIAL AGENTS | University Of Kentucky Research Foundation (US) | 2023-02-15 | — | — | EP | disclosed |
| CN-115515953-A | Novel imidazolidinone derivatives as inhibitors of protein kinases, in particular DYRK1A, CLK1 and/or CLK4 | 珀哈制药公司 | 2022-12-23 | — | — | CN | disclosed |
| CN-115380027-A | Novel antimalarial agents | 肯塔基大学研究基金会 | 2022-11-22 | — | — | CN | disclosed |
| CN-109970708-B | Cannabinoid receptor modulators | 艾尼纳制药公司 | 2022-06-21 | — | — | CN | disclosed |
| CN-110248937-B | 4, 5-Cyclic 1,2, 4-triazolones | 拜耳股份有限公司 | 2022-03-29 | — | — | CN | disclosed |